Digital GaitCare - Therapy Monitoring in the Home Environment of Patients With Parkinson

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

31 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-24

Study Completion Date

2022-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gait disturbances and movement restrictions occur frequently in Parkinson's disease. Patient-centered monitoring with objective aids in the patient's daily life, supports and promotes therapy decisions made by physicians and patients. Technical, sensor-based monitoring has the potential to generate objective target parameters at any point in time during therapy (patient journey), representing the state of health and its progression, and to make this information available to physicians and patients via telemedical data management. In this study, the gait analysis system "Mobile GaitLab Home 2.0", consisting of sensors for gait data acquisition, a smartphone application for study participants (Mobile GaitLab app) and a web portal for physicians (Mobile GaitLab portal) is used for data collection.

The research question is divided into three sub-objectives: First, the study explores and tests how technically generated parameters of sensor-based gait analysis can map the symptom "bradykinesis". The second goal is the explorative investigation of how a tele-health service support with low-threshold access to medical professionals, can be integrated into the care process. The third goal is the implementation evaluation of the technological developments. Here, it is examined to determine the extent to which the implementation of gait data and patient feedback (PROMs) in the patient-centered care process within the framework of clinical decision support contributes to early gait-associated therapy optimization and thus improves the general health of patients and how initial indications of positive care effects for patients can be derived.

During a 60-day observation phase, study participants use the gait analysis system, which records their gait pattern throughout the day and collects data via the Mobile GaitLab app. Study participants are asked to perform standardized gait tests in the home environment several times a day, in addition to continuous measurements during the awake phase. Frequency of data collection is controlled by Mobile GaitLab Home 2.0 and can be flexibly adjusted to the study participant's health status and therapy. The Mobile GaitLab app uses questionnaires to record data on gait safety, activity, general well-being, and events relevant to the disease. An evaluation of these data (PROMs) and the results from the gait analyses, are visualized for the study participants via the Mobile GaitLab app.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identification of Motor Symptoms Related to Parkinson's Disease Using Motion Tracking Sensors at Home

NCT03366558

Parkinson Disease

COMPLETED

Free-living Monitoring of Parkinson's Disease Using Smart Objects

NCT05830253

Parkinson Disease

COMPLETED

Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease

NCT01648803

Parkinson Disease

COMPLETED

Stability and Balance in Locomotion Through Exercise

NCT01856244

Parkinson's Disease

COMPLETED PHASE1

Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes

NCT00139321

Gait Disorders, Neurologic

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Gait Disorders, Neurologic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

Enrolled patients receive a medical device which monitors gait quality and collects information about the patients health status. Possible changes of intervention (drug or physical therapy) within the observational phase (8 weeks) are initiated and prescribed by physicians as a result of routine care process or patient contact based on their (deteriorated) health status. With the chosen endpoints, changes of patients empowerment, gait quality and system usability by using a monitoring device are monitored.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Idiopathic Parkinson's disease (H\&Y I-IV)
* Age \> 18 years
* Ability to walk \> 4 x 10 m without assistance
* Ability to speak and read
* Ability to use an application that can be mapped on a smart device
* Informed consent of the study participant
* Willingness of the study participant to take therapy measures (e.g., medication therapy, exercise therapy)

Exclusion Criteria

* Tremor-dominant Parkinson's syndrome without involvement of the lower extremities
* Aphasia and alexia
* Visual disturbances that make reading impossible
* Higher-grade movement disorders, with high risk of falls and non-independent ability to walk
* Higher grade cognitive deficits
* Inability of the study participant to understand the information and procedures of the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No